Why do life-changing medical innovations often struggle to reach the patients who need them most? In this episode of Patient Advocacy Voices, Esther Krofah of the Milken Institute moderates a powerful conversation with senior Sanofi leaders across immunology, vaccines, diabetes, and policy on the systemic barriers that stand between scientific breakthroughs and ensuring access for patients in need. The conversation was recorded in February 2025 at the Sanofi Patient Advocacy Council.

You’ll hear candid insights on:

• The "last mile" problem in getting therapies to patients
• Real-world examples of how insurance hurdles delay or deny care
• Policy shifts that could better reward innovation while reducing patient burden
• The urgent need for representative clinical trial recruitment
• How collaboration across advocacy, industry, and government can drive change

This episode offers both a frank view of patient access challenges and a clear call to action for working together, boldly and specifically, to make the system work better for patients.

How do you drive awareness for a rare disease with a name that’s difficult to even pronounce and a wide range of symptoms that mimic other conditions?

In this episode, host Eric Racine and co-host Preeya George-Guiser sit down with Mary Jo Strobel, Executive Director of the American Partnership for Eosinophilic Disorders (APFED), about the organization’s strategic approach to rare disease advocacy.

Mary Jo shares how APFED blends creativity, strategy, and a patient-centered approach to raise awareness and improve lives for patients living with eosinophil-associated diseases.

From creative targeted awareness campaigns to evidence-based initiatives, this conversation highlights how cross-sector collaboration can accelerate correct diagnosis and treatment and create lasting change in rare disease communities.

How will the shifting U.S. healthcare policy landscape impact patients? It’s an important topic that many patient advocates are thinking about today.

This month’s special episode features a thought-provoking panel discussion recorded during the Sanofi Patient Advocacy Council meeting in Washington, D.C., where panelists dove into this topic. Adam Gluck, SVP and Head, U.S. and Specialty Care Corporate Affairs at Sanofi moderated the panel, which featured Randy Rutta, CEO of the National Health Council (NHC) and Matt Eyles, former President and CEO of America's Health Insurance Plans (AHIP).

Tune in to hear the discussion, where the panelists shared insights around the biggest risks and opportunities for patient access and affordability in the current shifting policy landscape. They also emphasized the importance of collaboration between all stakeholders across the healthcare sector to drive truly meaningful changes for patients.